Clinical Trial Update: A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating thalidomide for refractory uremic pruritus in haemodialysis patients is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemodialysis-related Condition
• Uremic Pruritus

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: RenJi Hospital | Conditions: Haemodialysis, Uremic Pruritus | Phase 4 | Status: UNKNOWN